Journal
NUCLEIC ACIDS RESEARCH
Volume 36, Issue 7, Pages 2338-2352Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkn068
Keywords
-
Categories
Funding
- NIGMS NIH HHS [R01 GM057286] Funding Source: Medline
Ask authors/readers for more resources
U1 interference (U1i) is a novel method to block gene expression. U1i requires expression of a 5'-end-mutated U1 snRNA designed to base pair to the 3-terminal exon of the target genes pre-mRNA that leads to inhibition of polyadenylation. Here, we show U1i is robust (>= 95) and a 10-nt target length is sufficient for good silencing. Surprisingly, longer U1 snRNAs, which could increase annealing to the target, fail to improve silencing. Extensive mutagenesis of the 10-bp U1 snRNA:target duplex shows that any single mismatch different from GU at positions 38, destroys silencing. However, mismatches within the other positions give partial silencing, suggesting that off-target inhibition could occur. The specificity of U1i may be enhanced, however, by the fact that silencing is impaired by RNA secondary structure or by splicing factors binding nearby, the latter mediated by Arginine-Serine (RS) domains. U1i inhibition can be reconstituted in vivo by tethering of RS domains of U1-70K and U2AF65. These results help to: (i) define good target sites for U1i; (ii) identify and understand natural cellular examples of U1i; (iii) clarify the contribution of hydrogen bonding to U1i and to U1 snRNP binding to 5 splice sites and (iv) understand the mechanism of U1i.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available